HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Recombivax HB

recombinant hepatitis B vaccine; was SY to hepatitis B vaccine (NM); use hepatitis B vaccine (NM) to search through 1992
Also Known As:
Recombivax HBR; Recombivax-HB
Networked: 12 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cassidy, W M: 2 articles (12/2001 - 04/2001)
2. Wilson, Craig M: 1 article (06/2010)
3. Xu, Jiahong: 1 article (06/2010)
4. Cunningham, Coleen K: 1 article (06/2010)
5. Kapogiannis, Bill G: 1 article (06/2010)
6. Rudy, Bret J: 1 article (06/2010)
7. Adolescent Medicine Trials Network for HIV/AIDS Interventions: 1 article (06/2010)
8. Flynn, Patricia M: 1 article (06/2010)
9. Ahmad, Sushma: 1 article (06/2010)
10. Bethel, James: 1 article (06/2010)

Related Diseases

1. Hepatitis A (Hepatitis, Infectious)
2. Acquired Immunodeficiency Syndrome (AIDS)
3. Hepatitis B
04/01/2001 - "Hoping to increase hepatitis B (HB) vaccination of adolescents, we did the following: 1) studied if modified regimens of the recombinant HB vaccine, Recombivax HB (2 or 3 doses of 5 or 10 microg given over 4 or 6 months), induce protective anti-hepatitis B surface antibody [anti-HBsAb] levels (>/=10 mIU/mL) comparable to the recommended regimen (5 microg at 0 and 1, and 6 months); 2) measured early antibody response after a single dose; and 3) assessed immunologic memory after 2- and 3-dose regimens. "
07/01/2001 - "Adults who had never been vaccinated against hepatitis B were randomised to receive a vaccination course of either a present single antigen (S) vaccine (Recombivax-HB) or a novel triple antigen (S, pre-S1, and pre-S2) recombinant vaccine (Hepacare Medeva Pharma plc). "
03/01/2001 - "A total of 2875 infants (<1 year) (95.8%) achieved seroprotection with Engerix B; 701 (88.5%) achieved seroprotection with Recombivax/ HB-Vax II. Hepatitis B vaccination programs using either Engerix B or Recombivax/HB-Vax II can achieve high seroprotective response rates, particularly in childhood and adolescence. "
10/01/2005 - "Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease."
06/01/2010 - "A positive response (serum antibody > or =10 mIU/mL) to hepatitis B antigen was documented in 41 of 47 (87.2%; 95% confidence interval [CI] 74.3%-95.2%) Recombivax HB recipients and in 52 of 55 (94.6%; 95% CI, 84.9%-98.9%) Twinrix recipients (P = 0.295). "
4. Infection
5. Pain (Aches)

Related Drugs and Biologics

1. Antigens
2. twinrix
3. Hepatitis B Surface Antigens (HBsAg)
4. Vaccines
5. Engerix-B
6. Recombinant DNA (Recombinant DNA Research)
7. Heptavax B
8. Hepatitis B Vaccines (Hepatitis B Vaccine)
9. Ribosomal DNA (rDNA)
10. COMVAX

Related Therapies and Procedures

1. Injections